References
The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. (1997). A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The New England Journal of Medicine, 337(22), 1576–1583A.
Moss, A., Zareba, W., Hall, J., Klein, H., Wilber, D., Cannom, D., et al. (2002). Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. The New England Journal of Medicine, 346(12), 877–883.
Bardy, G., Lee, K., Mark, D., Poole, J., Packer, D., Boineau, R., et al. (2005). Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. The New England Journal of Medicine, 352(3), 225–237.
Maisal, W., & Kramer, D. (2008). Implantable cardioverter-defibrillator lead performance. Circulation, 117(21), 2721–2723.
Alter, P., Waldhans, S., Plachta, E., Moosdorf, R., & Grimm, W. (2005). Complications of implantable cardioverter defibrillator therapy in 440 consecutive patients. Pacing and Clinical Electrophysiology, 28(9), 926–932.
Bardy, G., Smith, W., Hood, M., Crozier, I., Melton, I., Jordaens, L., et al. (2010). An entirely subcutaneous implantable cardioverter-defibrillator. The New England Journal of Medicine, 363(1), 36–44.
Gold, M., Theuns, D., Knight, B., Sturdivant, J., Ellenbogen, K., Wood, M., et al. (2009). Arrhythmia detection by a totally subcutaneous S-ICD® system compared to transvenous single-chamber ICD systems with morphology discrimination. Heart Rhythm, 6(5S), S34.
Wathen, M., DeGroot, P., Sweeney, M., Stark, A., Otterness, M., Adkisson, W., et al. (2004). Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation, 110(17), 2591–2596.
Lerman, B., & Deale, O. (1990). Relation between transcardiac and transthoracic current during defibrillation in humans. Circulation Research, 67(6), 1420–1426.
Jolley, M., Stinstra, J., Pieper, S., MacLeod, R., Brooks, D., Cecchin, F., et al. (2008). A computer modeling tool for comparing novel ICD electrode orientations in children and adults. Heart Rhythm, 5(4), 565–572.
Tung, L., Tovar, O., Neunlist, M., Jain, S., & O’Neill, R. (1994). Effects of strong electrical shock on cardiac muscle tissue. Annals of the New York Academy of Sciences, 720, 160–175.
Walcott, G., Killingsworth, C., & Ideker, R. (2003). Do clinically relevant transthoracic defibrillation energies cause myocardial damage and dysfunction? Resuscitation, 59, 59–70.
Hasdemir, C., Shan, N., Rao, A., Acosta, H., Matsudaira, K., Neas, B., et al. (2002). Analysis of troponin I levels after spontaneous implantable cardioverter defibrillator shocks. Journal of Cardiovascular Electrophysiology, 13(2), 144–150.
Tokano, T., Bach, D., Chang, J., Davis, J., Souza, J., Zivin, A., et al. (1998). Effect of ventricular shock strength on cardiac hemodynamics. Journal of Cardiovascular Electrophysiology, 9(8), 791–797.
Zivin, A., Souza, J., Pelosi, F., Flemming, M., Knight, B., Goyal, R., et al. (1999). Relationship between shock energy and postdefibrillation ventricular arrhythmias in patients with implantable defibrillators. Journal of Cardiovascular Electrophysiology, 10(3), 370–377.
Killingworth, C., Livotsky, S., Melnick, S., Vance, F., Ideker, R., & Walcott, G. (2010). Shocks delivered via a subcutaneous defibrillation system cause less acute injury than transvenous leads in swine. Heart Rhythm, 7(5S), S186.
Poole, J., Johnson, G., Hellkamp, A., Anderson, J., Callans, D., Raitt, M., et al. (2008). Prognostic importance of defibrillator shocks in patients with heart failure. The New England Journal of Medicine, 359(10), 1009–1017.
Hohnloser, S., Kuck, K., Dorian, P., Roberts, R., Hampton, J., Hatala, R., et al. (2004). Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. The New England Journal of Medicine, 351(24), 2481–2488.
The DAVID trial Investigators. (2002). Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. Journal of the American Medical Association, 288(24), 3115–3123.
Sweeney, M., Ruetz, L., Belk, P., Mullen, T., Johnson, J., & Sheldon, T. (2007). Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachycardias a possible mechanism of proarrhythmia? Journal of the American College of Cardiology, 50(7), 614–622.
Himmrich, E., Przibille, O., Zellerhoff, C., Liebrich, A., Rosocha, S., Andreas, K., et al. (2003). Proarrhythmic effect of pacemaker stimulation in patients with implanted cardioverter-defibrillators. Circulation, 108(2), 192–197.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crozier, I. The subcutaneous defibrillator will replace the transvenous defibrillator. J Interv Card Electrophysiol 32, 73–77 (2011). https://doi.org/10.1007/s10840-011-9570-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-011-9570-4